Cargando…
Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Amyloid β (Aβ) plaque formation is a prominent cellular hallmark of Alzheimer’s disease (AD). To date, immunization trials in AD patients have not been effective in terms of curing or ameliorating dementia. In addition, γ-secretase inhibitor strategies await clinical improvements in AD. These approa...
Autores principales: | Gentier, Romina J., van Leeuwen, Fred W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557111/ https://www.ncbi.nlm.nih.gov/pubmed/26388726 http://dx.doi.org/10.3389/fnmol.2015.00047 |
Ejemplares similares
-
HUWE1 and TRIP12 Collaborate in Degradation of Ubiquitin-Fusion Proteins and Misframed Ubiquitin
por: Poulsen, Esben G., et al.
Publicado: (2012) -
Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease
por: Gentier, Romina J. G., et al.
Publicado: (2015) -
Selective Transgenic Expression of Mutant Ubiquitin in Purkinje Cell Stripes in the Cerebellum
por: Verheijen, Bert M., et al.
Publicado: (2016) -
Dysfunction of Protein Quality Control in Parkinsonism–Dementia Complex of Guam
por: Verheijen, Bert M., et al.
Publicado: (2018) -
Editorial: Ubiquitin and the Brain: Roles of Proteolysis in the Normal and Abnormal Nervous System
por: Hegde, Ashok N., et al.
Publicado: (2017)